Development of Microbiome Biobanks - Challenges and Opportunities.


Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
02 2021
Historique:
received: 04 05 2020
revised: 20 06 2020
accepted: 25 06 2020
pubmed: 18 8 2020
medline: 20 8 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

The microbiome research field is rapidly evolving, but the required biobanking infrastructure is currently fragmented and not prepared for the biobanking of microbiomes. The rapid advancement of technologies requires an urgent assessment of how biobanks can underpin research by preserving microbiome samples and their functional potential.

Identifiants

pubmed: 32800611
pii: S0966-842X(20)30188-8
doi: 10.1016/j.tim.2020.06.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-92

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

M J Ryan (MJ)

CABI, Egham, Surrey, UK. Electronic address: m.ryan@cabi.org.

M Schloter (M)

Helmholtz Zentrum München, National Research Center for Environmental Health, Research Unit for Comparative Microbiome Analysis, Oberschleissheim, Germany.

G Berg (G)

Institute of Environmental Biotechnology, Graz University of Technology, Graz, Austria.

T Kostic (T)

AIT Austrian Institute of Technology, Center for Health and Bioresources, Bioresources Unit, Tulln, Austria.

L L Kinkel (LL)

Department of Plant Pathology, University of Minnesota, Saint Paul, MN, USA.

K Eversole (K)

International Alliance for Phytobiomes Research, Lee's Summit, MO, USA; Eversole Associates, Bethesda, MD, USA.

J A Macklin (JA)

Agriculture and Agri-Food Canada, Ottawa, ON, Canada.

B Schelkle (B)

European Food Information Council, Brussels, Belgium.

M Kazou (M)

Laboratory of Dairy Research, Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Greece.

I Sarand (I)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.

B K Singh (BK)

Global Centre for Land Based Innovation, Hawkesbury Institute for the Environment, Western Sydney University, Penrith, Australia.

D Fischer (D)

Helmholtz Zentrum München, National Research Center for Environmental Health, Research Unit for Comparative Microbiome Analysis, Oberschleissheim, Germany.

E Maguin (E)

INRAE, MICALIS Institute, Metagenopolis, Jouy-en-Josas, France.

I Ferrocino (I)

Department of Agricultural, Forest and Food Science, University of Turin, Grugliasco, Italy.

N Lima (N)

Biological Engineering Centre, University of Minho, Braga, Portugal.

R S McClure (RS)

Pacific Northwest National Laboratory, Richland, WA, USA.

T C Charles (TC)

Waterloo Centre for Microbial Research, University of Waterloo, Waterloo, ON, Canada.

R S C de Souza (RSC)

Genomics for Climate Change Research Center, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.

G S Kiran (GS)

Department of Food Science and Technology, Pondicherry University, Puducherry, India.

H L Krug (HL)

Institute of Environmental Biotechnology, Graz University of Technology, Graz, Austria.

J Taffner (J)

Institute of Environmental Biotechnology, Graz University of Technology, Graz, Austria.

H Roume (H)

INRAE, MICALIS Institute, Metagenopolis, Jouy-en-Josas, France.

J Selvin (J)

Department of Microbiology, Pondicherry University, Puducherry, India.

D Smith (D)

CABI, Egham, Surrey, UK.

D Rybakova (D)

Institute of Environmental Biotechnology, Graz University of Technology, Graz, Austria.

A Sessitsch (A)

AIT Austrian Institute of Technology, Center for Health and Bioresources, Bioresources Unit, Tulln, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH